Cargando…

The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies

BACKGROUND: In 2017, varicella vaccination became mandatory for all children in Italy, based on a two-dose schedule administered at 12–15 months of age and 5 to 6 years of age. Varicella vaccines are available in different formulations (as a single vaccine or as a combination vaccine together with m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azzari, C, Baldo, V, Giuffrida, S, Gani, R, O’Brien, E, Alimenti, C, Daniels, V J, Wolfson, L J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294569/ https://www.ncbi.nlm.nih.gov/pubmed/32606844 http://dx.doi.org/10.2147/CEOR.S229685

Ejemplares similares

Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions
por: Bechini, Angela, et al.
Publicado: (2014)

Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model
por: Wolfson, Lara J., et al.
Publicado: (2019)

Estimating the Health and Economic Impact of Universal Varicella Vaccination in Jordan
por: Hayajneh, Wail, et al.
Publicado: (2017)

Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom
por: Pawaskar, Manjiri, et al.
Publicado: (2021)

Budget impact analysis of multiple varicella vaccination strategies: a Mexico perspective
por: Graham, Jonathan, et al.
Publicado: (2019)

Cost effectiveness and budget impact of universal varicella vaccination in Russia
por: Marijam, Alen, et al.
Publicado: (2022)

Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States
por: Pawaskar, Manjiri, et al.
Publicado: (2022)

Cost-Effectiveness of Varicella Vaccination
por: Yasri, Sora, et al.
Publicado: (2019)

The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014
por: Chan, D. Y. W., et al.
Publicado: (2018)

Economic burden of varicella in Europe in the absence of universal varicella vaccination
por: Pawaskar, Manjiri, et al.
Publicado: (2021)

2477. Impact of Varicella Vaccination in the United States (US): A Dynamic Model-Based Analysis
por: Wolfson, Lara, et al.
Publicado: (2018)

Epidemiological Impact and Cost-Effectiveness of Varicella Vaccination Strategies in the United Kingdom
por: Akpo, Esse Ifebi Herve, et al.
Publicado: (2020)

2467. Timeliness of Childhood Vaccination With the Combination Measles–Mumps–Rubella–Varicella Vaccine vs. the Separate Measles–Mumps–Rubella and Varicella Vaccines in the United States
por: Wolfson, Lara, et al.
Publicado: (2018)

Economic Evaluation of Universal Varicella Vaccination in Mexico
por: Chacon-Cruz, Enrique, et al.
Publicado: (2021)

Cost-effectiveness of Varicella Vaccination Program in Iran
por: Esmaeeli, Shooka, et al.
Publicado: (2017)

2478. Impact of 20 Years of Varicella Vaccination on the Epidemiology of Herpes Zoster in the United States: An Interrupted Time Series Analysis
por: Wolfson, Lara, et al.
Publicado: (2018)

Varicella Vaccine
por: Duff, Patrick
Publicado: (1996)

1389. Economic Evaluation of Universal Varicella Vaccination in Mexico
por: Chacon-Cruz, Enrique, et al.
Publicado: (2020)

Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy
por: Giaquinto, Carlo, et al.
Publicado: (2018)

Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectiveness
por: Burgess, Colleen, et al.
Publicado: (2023)

Varicella: epidemiological aspects and vaccination coverage in the Veneto Region
por: Baldo, Vincenzo, et al.
Publicado: (2009)

Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997–2005
por: Quian, J, et al.
Publicado: (2008)

Correction: Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectiveness
por: Burgess, Colleen, et al.
Publicado: (2023)

Epidemiology of Breakthrough Varicella after the Implementation of a Universal Varicella Vaccination Program in Taiwan, 2004–2014
por: Cheng, Hao-Yuan, et al.
Publicado: (2018)

Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data
por: Goldman, G.S., et al.
Publicado: (2013)

Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
por: Gershon, Anne A, et al.
Publicado: (2021)

1461. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States
por: Leung, Jessica W, et al.
Publicado: (2022)

Estimating the health economic impact of the universal varicella vaccination in Argentina from 2015 to 2019
por: Giglio, Norberto, et al.
Publicado: (2023)

No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination
por: Carryn, Stephane, et al.
Publicado: (2021)

The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Slovenia
por: Burgess, Colleen, et al.
Publicado: (2022)

Evaluation of a vaccination strategy by serosurveillance data: The case of varicella
por: Tafuri, Silvio, et al.
Publicado: (2015)

2476. Impact of the Vaccination Strategy on Varicella Burden Disease in Argentina
por: Neyro, Silvina, et al.
Publicado: (2018)

Global varicella vaccination programs
por: Lee, Young Hwa, et al.
Publicado: (2022)

Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella
por: Wu, Po-Yuan, et al.
Publicado: (2013)

The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study
por: Melegaro, Alessia, et al.
Publicado: (2018)

Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus
por: Heusel, Ethan H., et al.
Publicado: (2020)

Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy
por: IGIDBASHIAN, S., et al.
Publicado: (2020)

Socioeconomic Determinants in Vaccine Hesitancy and Vaccine Refusal in Italy
por: Bertoncello, Chiara, et al.
Publicado: (2020)

Clinical and economic impact of universal varicella vaccination in Norway: A modeling study
por: Pawaskar, Manjiri, et al.
Publicado: (2021)

Clinical efficacy and effectiveness of alternative varicella vaccination strategies: An overview of reviews
por: Ahern, Susan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4j90vvcgs8undt6r3vqqc2juq6